Title: | Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences |
Journal: | Nature Genetics |
Published: | 27 Aug 2024 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39192095/ |
DOI: | https://doi.org/10.1038/s41588-024-01884-7 |
Title: | Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences |
Journal: | Nature Genetics |
Published: | 27 Aug 2024 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39192095/ |
DOI: | https://doi.org/10.1038/s41588-024-01884-7 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Telomeres protect chromosome ends from damage and their length is linked with human disease and aging. We developed a joint telomere length metric, combining quantitative PCR and whole-genome sequencing measurements from 462,666 UK Biobank participants. This metric increased SNP heritability, suggesting that it better captures genetic regulation of telomere length. Exome-wide rare-variant and gene-level collapsing association studies identified 64 variants and 30 genes significantly associated with telomere length, including allelic series in ACD and RTEL1. Notably, 16% of these genes are known drivers of clonal hematopoiesis - an age-related somatic mosaicism associated with myeloid cancers and several nonmalignant diseases. Somatic variant analyses revealed gene-specific associations with telomere length, including lengthened telomeres in individuals with large SRSF2-mutant clones, compared with shortened telomeres in individuals with clonal expansions driven by other genes. Collectively, our findings demonstrate the impact of rare variants on telomere length, with larger effects observed among genes also associated with clonal hematopoiesis.</p>
Application ID | Title |
---|---|
6077 | Telomere length measurement in UK Biobank: advancing understanding of biological ageing and age-related diseases |
Enabling scientific discoveries that improve human health